Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Serum-free and Speciality Media
Authors:
Hill C and Boreikaite
In:
Mol Cell (2019) 73: 1217-1231
Categories:
Serum-free and Speciality Media
Authors:
Panevska A and Hodnik V
In:
Scientific Reports (2019) 9(1): 5073
Categories:
Serum-free and Speciality Media
Authors:
Aspelund A, Tammela T, Antila S, Nurmi H, Leppänen VM, Zarkada G, Stanczuk L, Francois M, Mäkinen T, Saharinen P, Immonen I, Alitalo K
In:
J Clin Invest (2014) 124(9): 3975-86
Categories:
Serum-free and Speciality Media
Authors:
Lin B1, Meng H1, Bing H1, Zhangsun D1, Luo S1.
In:
Biomed Res Int. (2014) 691480: Epub 2014 Jul 20
Categories:
Serum-free and Speciality Media
Authors:
Nair S1, Sanchez-Martinez S, Ji X, Rein A.
In:
J Virol (2014) 88(7): 3850-60
Categories:
Serum-free and Speciality Media
Authors:
Patrone M, Carinhas N, Sousa MQ, Peixoto C, Ciferri C, Carfì A, Alves PM
In:
PLoS ONE (2014) 9(3): e90753
Categories:
Serum-free and Speciality Media
Authors:
Bouillon A1, Giganti D, Benedet C, Gorgette O, Pêtres S, Crublet E, Girard-Blanc C, Witkowski B, Ménard D, Nilges M, Mercereau-Puijalon O, Stoven V, Barale JC.
In:
J Biol Chem (2013) 288(25): 18561-73
Categories:
Serum-free and Speciality Media
Authors:
Seelhorst K1, Stacke C, Ziegelmüller P, Hahn U.
In:
Glycobiology (2013) 23(5): 559-67
+ Show All